These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1976233)

  • 1. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.
    Schmutz M; Portet C; Jeker A; Klebs K; Vassout A; Allgeier H; Heckendorn R; Fagg GE; Olpe HR; van Riezen H
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):61-6. PubMed ID: 1976233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
    Chapman AG; Graham JL; Patel S; Meldrum BS
    Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration.
    Cotterell KL; Croucher MJ; Bradford HF
    Eur J Pharmacol; 1992 Apr; 214(2-3):285-7. PubMed ID: 1355438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
    D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
    Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Apr; 234(2-3):237-45. PubMed ID: 8097722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats.
    De Sarro G; De Sarro A
    Eur J Pharmacol; 1992 May; 215(2-3):221-9. PubMed ID: 1396987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds.
    Croucher MJ; Cotterell KL; Bradford HF
    Neurochem Res; 1992 May; 17(5):409-13. PubMed ID: 1356242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats.
    Wlaź P; Ebert U; Löscher W
    Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effects of CGP 39551.
    Velísek L; Vachová D; Mares P
    Pharmacol Biochem Behav; 1997 Mar; 56(3):493-8. PubMed ID: 9077588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
    De Sarro G; De Sarro A; Ammendola D; Patel S
    Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551.
    Pozza MF; Olpe HR; Brugger F; Fagg GE
    Eur J Pharmacol; 1990 Jun; 182(1):91-100. PubMed ID: 1976098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice.
    Czechowska G; Dziki M; Pietrasiewicz T; Kleinrok Z; Turski WA; Czuczwar SJ
    Eur J Pharmacol; 1993 Feb; 232(1):59-64. PubMed ID: 8096188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
    D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
    Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlormethiazole anticonvulsive efficacy diminished by N-methyl-D-aspartate but not kainate in mice.
    Pilip S; Urbanska EM; Czuczwar SJ; Kleinrok Z; Turski WA
    Eur J Pharmacol; 1998 Mar; 345(3):257-60. PubMed ID: 9592024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.